SCHEMBL5396221

SCHEMBL5396221

C/C=C(\C)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL478029 1.00
SCHEMBL537514 1.00
SCHEMBL1736432 0.95
SCHEMBL10961802 0.74
SCHEMBL10961805 0.74
SCHEMBL25381253 0.74
SCHEMBL6294842 0.74
SCHEMBL554911 0.74
SCHEMBL554910 0.74
SCHEMBL7135962 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112047870-B Preparation method of 7-alkyl indole derivative 浙江工业大学 2021-10-12 CN claimed
CN-112047870-A Preparation method of 7-alkyl indole derivative 浙江工业大学 2020-12-08 CN claimed
US-20240261288-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER THE EHE FOUNDATION 2024-08-08 US disclosed
CN-117561061-A Combination of 3- (imidazol-4-yl) -4- (amino) -benzenesulfonamide TEAD inhibitors with EGFR inhibitors and/or MEK inhibitors for the treatment of lung cancer 医肯纳肿瘤学公司 2024-02-13 CN disclosed
WO-2023122754-A1 PROCESSES AND INTERMEDIATES FOR PREPARING GB13, GB22 AND HIMGALINE THE SCRIPPS RESEARCH INSTITUTE (US) 2023-06-29 WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed
US-11332426-B2 Method of preparing trisubstituted ethylene compounds TRUSTEES OF BOSTON COLLEGE (US) 2022-05-17 US disclosed
CN-112047870-B Preparation method of 7-alkyl indole derivative 浙江工业大学 2021-10-12 CN disclosed
CN-112174787-A Preparation method of trans-2-methyl-2-butenal 浙江凯普化工有限公司 2021-01-05 CN disclosed
CN-112174787-A Preparation method of trans-2-methyl-2-butenal 浙江凯普化工有限公司 2021-01-05 CN disclosed
US-7285410-B2 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-10-23 US disclosed
US-7220562-B2 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-22 US disclosed
US-7198926-B2 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-04-03 US disclosed
US-20070037264-A1 Using trangenic microorganism having nitrilase and amidase activities to convert (E,Z)-2-methyl-2-butenenitrile into (E and Z)-2-methyl-2-butenoic acids BRAMUCCI MICHAEL G 2007-02-15 US disclosed
US-20060115883-A1 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids BRAMUCCI MICHAEL G 2006-06-01 US disclosed
WO-2004101513-A2 PREPARATION OF (E)- AND (Z)-2-METHYL-2-BUTENOIC ACIDS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2004-11-25 WO disclosed
US-20040224395-A1 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids E. I. DU PONT DE NEMOURS AND COMPANY 2004-11-11 US disclosed
US-5245064-A Catlaysis GASSMAN PAUL G (US) 1993-09-14 US disclosed
US-4827004-A ANTIULCER AGENTS HOFFMANN-LA ROCHE INC. (US) 1989-05-02 US disclosed